Page 1 of 5
Next
| Politician | Branch | Asset | Ticker | Category | Type | Transaction Date | Amount | Filing Date |
|---|---|---|---|---|---|---|---|---|
| Kevin Hern | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Sale | Aug. 27, 2026 | $$15,001 - $50,000 | Sept. 25, 2026 |
| Arjun Mody | executive | Novartis AG Common Stock (NVS) | NVS | STOCK | Sale | Jan. 30, 2026 | $$1,001 - $15,000 | April 10, 2026 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Sale | Oct. 31, 2025 | $$1,001 - $15,000 | Nov. 21, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Sale | Oct. 30, 2025 | $$1,001 - $15,000 | Nov. 21, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Purchase | Oct. 30, 2025 | $$1,001 - $15,000 | Nov. 21, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Sale | Sept. 25, 2025 | $$1,001 - $15,000 | Oct. 22, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) [ST] | NVS | STOCK | S (partial) | Sept. 25, 2025 | $$1,001 - $15,000 | Oct. 23, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) [ST] | NVS | STOCK | P | Sept. 11, 2025 | $$1,001 - $15,000 | Oct. 23, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Purchase | Sept. 11, 2025 | $$1,001 - $15,000 | Oct. 22, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Sale | July 22, 2025 | $$1,001 - $15,000 | Aug. 13, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Purchase | June 17, 2025 | $$1,001 - $15,000 | Aug. 13, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Purchase | June 11, 2025 | $$1,001 - $15,000 | Aug. 13, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Sale | June 10, 2025 | $$1,001 - $15,000 | Aug. 13, 2025 |
| Lisa McClain | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Purchase | June 9, 2025 | $$1,001 - $15,000 | Aug. 13, 2025 |
| George Whitesides | house | Novartis AG Common Stock (NVS) | NVS | STOCK | Sale | March 24, 2025 | $$100,001 - $250,000 | April 23, 2025 |
| Pete Sessions | house | Envista Holdings Corporation Common Stock (NVST) | NVST | STOCK | Sale | June 6, 2024 | $$1,001 - $15,000 | June 6, 2024 |
| Daniel Goldman | house | Novartis AG (NVS) | NVS | STOCK | Sale | July 10, 2023 | $$50,001 - $100,000 | Aug. 13, 2023 |
| Rohit Khanna | house | NOVARTIS AG ADR S | NVS | STOCK | Purchase | April 5, 2023 | $A | Aug. 17, 2020 |
| Daniel Goldman | house | Novartis AG (NVS) | NVS | STOCK | Purchase | March 31, 2023 | $$50,001 - $100,000 | April 17, 2023 |
| Daniel Goldman | house | Novartis AG (NVS) | NVS | STOCK | Sale (partial) | Feb. 27, 2023 | $$15,001 - $50,000 | March 20, 2023 |
| Kevin Hern | house | Novartis AG (NVS) | NVS | STOCK | Sale | Jan. 31, 2023 | $$1,001 - $15,000 | Feb. 14, 2023 |
| William J Burns | executive | Novartis | NVS | STOCK | Sale | Oct. 24, 2022 | $$1,001 - $15,000 | Jan. 31, 2023 |
| John Rutherford | house | Novartis AG (NVS) | NVS | STOCK | Sale | March 16, 2022 | $$1,001 - $15,000 | April 19, 2022 |
| Donald Sternoff Beyer | house | Novartis Ag (NVS) | NVS | STOCK | Sale | Feb. 28, 2022 | $$1,001 - $15,000 | March 3, 2022 |
| Lois Frankel | house | NuVasive, Inc. (NuVA) | NVSI | STOCK | Sale | Feb. 14, 2022 | $$1,001 - $15,000 | Feb. 27, 2022 |